Dennis S. Charney

Affiliations: 
Neurosciences Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Area:
Neuroscience Biology, Mental Health, Clinical Psychology
Google:
"Dennis Charney"
Mean distance: 19.29
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Feder A, Fred-Torres S, Southwick SM, et al. (2019) The Biology of Human Resilience: Opportunities for Enhancing Resilience Across the Life Span. Biological Psychiatry. 86: 443-453
Jha MK, Qamar A, Vaduganathan M, et al. (2019) Screening and Management of Depression in Patients With Cardiovascular Disease: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 73: 1827-1845
Costi S, Soleimani L, Glasgow A, et al. (2019) Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Krystal JH, Abdallah CG, Sanacora G, et al. (2019) Ketamine: A Paradigm Shift for Depression Research and Treatment. Neuron. 101: 774-778
Guo W, Machado-Vieira R, Mathew S, et al. (2019) Correction: Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression. Translational Psychiatry. 9: 108
Iacoviello BM, Murrough JW, Hoch MM, et al. (2018) A randomized, controlled pilot trial of the Emotional Faces Memory Task: a digital therapeutic for depression. Npj Digital Medicine. 1
Guo W, Machado-Vieira R, Mathew S, et al. (2018) Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression. Translational Psychiatry. 8: 280
Sayed S, Van Dam NT, Horn SR, et al. (2017) A randomized dose-ranging study of neuropeptide Y in patients with posttraumatic stress disorder. The International Journal of Neuropsychopharmacology
Murrough JW, Charney DS. (2017) Corticotropin-Releasing Factor Type 1 Receptor Antagonists for Stress-Related Disorders: Time to Call It Quits? Biological Psychiatry. 82: 858-860
Murrough JW, Wade E, Sayed S, et al. (2017) Dextromethorphan/quinidine pharmacotherapy in patients with treatment resistant depression: A proof of concept clinical trial. Journal of Affective Disorders. 218: 277-283
See more...